Contrafect

Developer of therapeutics for the treatment of antibiotic-resistant infections

placeYonkers, New York, United States calendar_todayFounded 2008 groups23 employees language contrafect.com

Registered entities

Investor mix

7 investors on record; lead investors include Maxim Group.

Investor typeCountShare
Venture capital114%
Private equity114%
Bank & private debt114%
Other / undisclosed457%
Coming soon